by Igen BioLab Group | May 7, 2021 | News, Publications
The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint inhibitors (ICIs), whereas supplementation of distinct bacterial species restores...
by Igen BioLab Group | Apr 21, 2021 | News, Publications
Intestinal microbiota-derived metabolites have biological importance for the host. Polyamines, such as putrescine and spermidine, are produced by the intestinal microbiota and regulate multiple biological processes. Increased colonic luminal polyamines promote...
by Igen BioLab Group | Apr 5, 2021 | News, Publications
Emerging evidence indicates that gut microbiota affect the response to anticancer therapies by modulating the host immune system. In this study, we investigated the impact of gut microbiota on immune-mediated trastuzumab antitumor efficacy in preclinical models of...
by Igen BioLab Group | Mar 12, 2021 | Events
From September 14 to 16, 2021, will be held in Madrid the XII Workshop Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP) / I Congress Iberoamerican Society of Microbiota, Probiotics and Prebiotics. The program will address the following topics: Our...
by Igen BioLab Group | Mar 5, 2021 | News, Publications
Microbiota: Set of microorganisms in a specific location or sample that inhabit all the surfaces of our organism. Functions: Maintenance of barrier functionBalance of species of microorganismsLocal innate and adaptive immunity A human cell is composed of three...
